Bacteria are named using binomial nomenclature: a capitalized genus name followed by a lowercase species epithet, both italicized, governed by the International Code of Nomenclature of Prokaryotes (ICNP). A valid name must be published in the International Journal of Systematic and Evolutionary Microbiology and appear on the Approved Lists. The name is a label tied to a type strain, not a description of what the organism does.

That distinction matters more than it first appears. A bacterial name is a permanent filing address for a physical reference culture, and the rules that govern it were built to keep that address stable even when the science around it changes. Understanding how the names are made explains why some are elegant Latin, some are clumsy acronyms, and why a few have been quietly renamed out from under clinicians.

The two-part name and what each part does

Every valid bacterial name has two components. The genus is the broader category, always capitalized and always italicized. The species epithet is lowercase, italicized, and never stands alone. Writing "E. coli" is shorthand, acceptable after the full name appears once. Writing "coli" by itself is meaningless.

The epithet can honor a person (Escherichia coli is named for Theodor Escherich), describe a habitat (Lactobacillus acidophilus, acid-loving), describe a shape (Bacillus, small rod), or record a location. The genus carries more taxonomic weight: it groups organisms presumed to share a lineage, while the epithet distinguishes within that group.

A full formal citation also carries an author and year. When you see "Escherichia coli (Migula 1895) Castellani and Chalmers 1919," you are reading the original describer and the person who later placed the organism in its current genus. This author citation is not decoration. It is the audit trail.

Here is the mechanism one level deeper: the name is anchored to a type strain, a living culture deposited in at least two recognized culture collections in different countries. If the type strain dies or is contaminated, the name loses its physical referent. That is why culture collections like the American Type Culture Collection function as the backbone of the entire nomenclature system. A name without an accessible type strain is a name without a foundation.

The rules that make a name valid

Validity is a legal status, not a scientific judgment. A name becomes valid only when it is published in the International Journal of Systematic and Evolutionary Microbiology and simultaneously appears on the Approved Lists of Bacterial Names or a subsequent validation list. The Approved Lists were established on January 1, 1980, and names published before that date that did not make the list effectively ceased to exist for nomenclatural purposes.

The rules that govern naming include several concrete requirements:

The genus and species must be formed according to Latin grammar, with correct gender agreement between them. The name must be published in the International Journal of Systematic and Evolutionary Microbiology (or validated there) to be valid. A type strain must be designated and deposited in at least two culture collections in different countries. The name must not duplicate an existing valid name (homonym rule). The description must be based on a characterized, viable culture, not a gene sequence alone. The proposed name must follow the rules of the current revision of the International Code of Nomenclature of Prokaryotes.

The red flags are worth stating plainly. A name that appears only in a preprint is not valid. A name that appears only in a patent is not valid. A name proposed purely from metagenomic sequence, with no cultured isolate, cannot currently receive a valid name under the code's cultured-isolate requirement. Watch for these in literature searches: they look like names, they read like names, and they are not.

Note also that the code changes. The most recent substantial revision was published in 2022, and the rules on genome-based naming are under active discussion. What counts as valid is a moving target at the margins.

How a new species actually gets named

The process is more procedural than most people assume. A researcher isolates an organism, characterizes it, and decides it represents something new. That decision is not a matter of opinion. It rests on a polyphasic approach: phenotypic traits, chemotaxonomic markers, and genotypic data, with whole-genome sequence comparison now central.

The modern threshold most often cited is 95 to 96 percent average nucleotide identity (ANI) for genus-level separation and roughly 70 percent DNA-DNA hybridization historically, now largely replaced by ANI around 95 percent for species boundaries. These numbers are conventions, not laws of nature, and they are debated. A pair of strains at 94.9 percent ANI sits uncomfortably close to a boundary that humans drew.

The naming sequence runs in a defined order:

Isolate and culture the organism to purity. Characterize phenotype, growth conditions, and metabolism. Sequence the genome and compare against type strains. Deposit the type strain in two culture collections. Publish the description in IJSEM with a proposed name. The name enters the validation list and becomes valid.

The counterintuitive detail: a name can be perfectly valid and still be wrong. Validity is a nomenclatural property. Correctness is a taxonomic judgment, and the two are decided by different communities. A validly published name that later proves to belong to an existing species does not disappear; it becomes a synonym, and the older valid name takes priority under the rule of priority.

The renaming problem and why names move

Priority means the earliest validly published name wins. This rule, essential for stability, guarantees that reclassification produces churn. When a genus is split, species get new genus names. When two genera merge, one name survives and the other becomes a synonym.

The clinical consequences are real. In 2020, the genus Lactobacillus was reclassified into 25 genera based on genome analysis, and many species familiar to the food and probiotic industries acquired new names. A product label listing a species under its former name may now be technically outdated. Scientists generally accept the new names, but the transition takes years and creates genuine confusion in labeling and regulation. Similarly, the renaming of Clostridium difficile to Clostridioides difficile in 2016 reflected a real phylogenetic distinction, but the older name persists widely in clinical settings.

The professional caveat is this: taxonomy is a hypothesis about relatedness, and hypotheses get revised. A name is a snapshot, not a verdict. The rule of priority means the oldest valid name has legal standing, but it does not mean the oldest name is the most useful one. Nomenclature and taxonomy serve different masters, and when they conflict, the code prioritizes stability while working scientists prioritize accuracy.

What the name tells you and what it does not

Beginners often assume a bacterial name describes the organism. Sometimes it does. Often it does not, or it describes something discovered decades ago under different assumptions.

Component What it often encodes What it cannot tell you
Genus name Broad lineage grouping Whether the grouping is current
Species epithet Person, place, shape, or habitat Any clinical behavior
Author citation Original describer and later revisor How well the organism is characterized
Type strain The physical reference culture Whether the strain is typical
Strain designation A specific isolate within a species Anything about virulence

The table captures the core limitation: a name identifies a lineage, not a capability. Staphylococcus aureus and Staphylococcus epidermidis share a genus and differ enormously in clinical significance. The name tells you they are related. It tells you nothing about what they do.

Strain designations go further. E. coli O157:H7 carries an O antigen and H flagellar antigen serotype. That designation tells a clinician something the species name does not, but it is a serotype label layered on top of the binomial, not part of it. Confusing the layers is one of the most common errors in reading microbiology literature.

Practical rules for reading and using bacterial names

For anyone writing, teaching, or reading about bacteria, a few concrete habits prevent most errors. These are thresholds and formatting rules, not suggestions.

Formatting first. Italicize genus and species in running text; do not italicize the author citation. Capitalize the genus; never capitalize the species epithet, even when it honors a person. After the first full mention, abbreviate the genus to its initial and a period: E. coli. Spell it out again at the start of a new section.

Verify validity before citing. Check the name against the List of Prokaryotic Names with Standing in Nomenclature (LPSN) or the Approved Lists. If you need a species name for a clinical or regulatory document, confirm it is a validly published name, not a preprint designation or a patent name. When a name has changed, state both: "Clostridioides difficile (formerly Clostridium difficile)."

Check the type strain when it matters. For any work involving strain-level claims, confirm the type strain designation. A name without a known type strain is a name you cannot reliably reproduce against.

Treat sequence-only names with caution. Names proposed from metagenomic data, often written in quotation marks like "Candidatus," are provisional. The Candidatus prefix is itself an unofficial marker for uncultured organisms, not a valid name under the code. Do not treat a Candidatus designation as equivalent to a valid binomial in regulatory or clinical contexts.

The practical rule that reconciles the two thresholds: for species-level claims, require concordance between genome-based relatedness (ANI) and phenotypic characterization. Neither alone is sufficient, and the code's cultured-isolate requirement exists for exactly this reason.

Where the naming system strains

The code was designed for organisms that could be cultured, characterized, and deposited. A large fraction of environmental bacteria, by many estimates the majority, have never been cultured. The result is a nomenclature system with a growing blind spot: an enormous diversity of organisms that have sequence data and provisional names but no valid binomial.

The Candidatus convention is the current workaround. It flags organisms as uncultured and provisional, but it is not formally governed by the code in the way valid names are. The 2022 code revision and ongoing proposals aim to address genome-based naming, but the fundamental tension remains: a name anchored to a physical type strain cannot easily accommodate an organism that has never been grown.

The practical limit to state plainly: this article explains the stable mechanics of bacterial nomenclature, not current taxonomic opinion on any particular group. Specific genus and species assignments change, and the validity of any given name should be checked against LPSN at the time of use. The rules described here are stable. The names they govern are not.

The deeper point is that bacterial nomenclature is a deliberate compromise between two goals that pull against each other. Stability keeps communication possible across decades and disciplines. Accuracy keeps the system tied to evidence. The code chooses stability when forced, which is why priority rules and type strains dominate, and why renaming is slower and messier than the science that motivates it. Understanding that tension is what separates reading a name from understanding one.